The outcome of such a process, if taking place in vivo in malignancies with high TNFα expression - as is the case in breast cancer - may be high production of pro-tumorigenic factors by the tumor cells, including angiogenic ones (such as CXCL8 and CCL2). The gene discussed is CCL2; the disease is neoplasm.